Framycetin
As of the edition of 20 October 2026, Framycetin is a small molecule: marketed, first approved in 1966 (ES).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2000
- Kind
- Small molecule
- Brand name
- Aldoderma
- First approved
- 1 March 1966 (ES)
- Approvals on record
- 3 in 3 regions
- Holder of the most recent approval
- Cheplapharm Arzneimittel; 3 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Cheplapharm Arzneimittel | Applicant | 2000 to now |